Drug Profile
Anti fibrin monoclonal antibody 3B6/22 Tc 99m
Alternative Names: Tc 99m 3B6/22; Tc 99m anti-fibrin monoclonal antibody 3B6/22; ThromboViewLatest Information Update: 16 Mar 2018
Price :
$50
*
At a glance
- Originator Agenix
- Class Imaging agents; Monoclonal antibodies; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Deep vein thrombosis; Pulmonary embolism
Highest Development Phases
- Discontinued Deep vein thrombosis; Pulmonary embolism
Most Recent Events
- 07 Dec 2015 Discontinued - Phase-I for Pulmonary embolism (Diagnosis) in Australia (IV)
- 07 Dec 2015 Discontinued - Phase-II for Deep vein thrombosis (Diagnosis) in USA and Canada (IV)
- 07 Dec 2015 Discontinued - Phase-II for Pulmonary embolism (Diagnosis) in USA and Canada (IV)